Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial. (Q47410781)
Jump to navigation
Jump to search
scientific article published in June 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial. |
scientific article published in June 2004 |
Statements
Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial (English)
Barry Bresnihan
Richard Newmark
Sean Robbins